CN106754904B - The specific molecular label of cDNA a kind of and its application - Google Patents

The specific molecular label of cDNA a kind of and its application Download PDF

Info

Publication number
CN106754904B
CN106754904B CN201611196752.5A CN201611196752A CN106754904B CN 106754904 B CN106754904 B CN 106754904B CN 201611196752 A CN201611196752 A CN 201611196752A CN 106754904 B CN106754904 B CN 106754904B
Authority
CN
China
Prior art keywords
cdna
sequence
transposase
molecular label
specific molecular
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201611196752.5A
Other languages
Chinese (zh)
Other versions
CN106754904A (en
Inventor
曹林
张力军
聂俊伟
齐心
韩锦雄
瞿志鹏
张晨曦
徐晓昱
叶廷跃
王丹凤
刘辉辉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nanjing novozan Biotechnology Co., Ltd
Original Assignee
VAZYME BIOTECH (NANJING) Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by VAZYME BIOTECH (NANJING) Co Ltd filed Critical VAZYME BIOTECH (NANJING) Co Ltd
Priority to CN201611196752.5A priority Critical patent/CN106754904B/en
Publication of CN106754904A publication Critical patent/CN106754904A/en
Application granted granted Critical
Publication of CN106754904B publication Critical patent/CN106754904B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1096Processes for the isolation, preparation or purification of DNA or RNA cDNA Synthesis; Subtracted cDNA library construction, e.g. RT, RT-PCR
    • CCHEMISTRY; METALLURGY
    • C40COMBINATORIAL TECHNOLOGY
    • C40BCOMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B50/00Methods of creating libraries, e.g. combinatorial synthesis
    • C40B50/06Biochemical methods, e.g. using enzymes or whole viable microorganisms

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The specific molecular label and its application, the specific molecular label of a kind of cDNA includes: the universal primer sequence as shown in SEQ ID NO.1;The transposase joint sequence P7 as shown in SEQ ID NO.2;Random sequence: (N)n, N is random sequence, total n;With poly (T) sequence for sharing 30 T alkali, specific nucleotide sequence such as SEQ ID NO.3 institute.Specific molecular label is applied to cDNA to build in library, during RNA reverse transcription is at full-length cDNA, the specific molecular label is added in the end 5` of each cDNA, make each gene be it is unique, subsequent information analysis can according to the sequence of the special molecular label quantify sample in each gene.

Description

The specific molecular label of cDNA a kind of and its application
Technical field
The invention belongs to field of biotechnology, and in particular to the specific molecular label of cDNA a kind of and its application.
Background technique
In past twenty or thirty year, the extensive gene sequence analysis of two generations sequencing has greatly pushed genome and has turned The sequence of record group is analyzed.The sequencing of transcript profile is not because needing to be pre-designed entire transcript profile probe and can detecte unknown Transcript has gradually replaced the transcriptome analysis scheme that traditional chip gene expression profile becomes preferred.
Transcript profile refers in a certain moment, by the whole RNA of cell transcription out, including mRNA and non-coding RNA. Transcription group is exactly from the expression of rna level research gene, the case where studying genetic transcription in cell in integral level And the rule of transcriptional control.Different from genome, transcription group research contains the restriction in time and space, and same cell is not Under same growth period and growing environment, expression conditions are not exactly the same.Traditional transcriptome analysis needs to count Ten thousand are analyzed to hundreds of thousands of a cells, this be averaged a large amount of gene expression based on the method for population level, can not Disclose the heterogeneity of gene expression between cell.In addition, when target cell number is rare and is difficult to cultivate, this traditional point Analysis method is with regard to helpless, it is necessary to use unicellular transcriptome analysis technology.
The resolution ratio of unicellular transcript profile sequencing technologies is accurate to individual cells, to distinguish various cells in heterogeneous population The transcript profile feature of type provides strong tool.Traditional banking process uses the methods of ultrasonic wave, atomization fragmentation DNA needs larger amount of starting material, then by end repair, addition connector and etc. realization.However based on single celled Transcript profile sequencing starting total serum IgE amount is few, and this method is not suitable for, this is that many potential users is allowed to bring down a bit.
Construction cDNA library is the key technology step of unicellular transcriptome analysis, and method includes that separation is unicellular, thin Cellular lysate, mRNA reverse transcription are at cDNA, cDNA fragmentation and the several steps of adjunction head, amplified library.Single celled transcript profile is surveyed Sequence starting total serum IgE amount is few, uses poly thymidine (oligo-dT) as reverse in the case where not removing rRNA It records primer and obtains a large amount of full-length cDNA, using template switch (template-switching) activity of reverse transcriptase in cDNA 3 ends ` add the preceding paragraph joint sequence, this section of joint sequence can be used for full-length cDNA amplification and then obtain the sequence of entire mRNA, To avoid the Preference at 3 ends `.It can be added while interrupting at the both ends fragmentation DNA using the banking process of transposase Connector, by cumbersome DNA fragmentation, end repair and connection reaction and etc. become the simple enzymatic reaction of a step, it is this Method greatly reduces starting template amount and sample processing time.
The research of transcript profile can study gene function and gene structure from integral level, disclose point of bioprocess Handset reason, quantify each transcript wherein expression variation, be therefore widely used in biological study, medicament research and development, The fields such as basic research and clinical diagnosis.However, determining the absolute number of different genes in two different plant species or simple sample The very challenging property of abundance is measured, due to the Preference of PCR amplification, the mRNA of variable expression is in the PCR amplification for continuing library after The information reflected afterwards has inaccuracy, and subsequent analysis of biological information data can not true response gene expression quantity.
Summary of the invention
The purpose of the invention is to provide the specific molecular label of cDNA a kind of and its application, the specific molecular marks Label are added in 5 ends ` of each cDNA, make each gene be it is unique, subsequent information analysis can be according to the spy Each gene in the sequence quantization sample of opposite molecule label.
In order to achieve the above objectives, technical scheme is as follows:
A kind of specific molecular label of cDNA includes: universal primer sequence in full length sequence;Transposase joint sequence P7;Random sequence: (N)n, N is random sequence, total n;With poly (T) sequence;Wherein, the universal primer sequence such as SEQ Shown in ID NO.1, for transposase joint sequence as shown in SEQ ID NO.2, poly (T) sequence shares 30 i.e. T30VN of T base.
Preferably, the specific molecular label of cDNA of the present invention, nucleotide sequence as shown in SEQ ID NO.3, Particular sequence is as follows: AAGCAGTGGTATCAACGCAGAGTACGTCTCGTGGGCTCGG AGATGTGTATAAGAGACAG (N)nT30VN, wherein N is random sequence, and total n, N is selected from A, T, C, G;Preferably, n 5-10.
The specific molecular label of cDNA of the present invention builds the application in library in cDNA.The specific molecular of the cDNA Label is also applied to build in library using the cDNA that transposase interrupts.
The present invention also provides a kind of cDNA banking process interrupted using transposase comprising following steps:
1) separation is unicellular, will discharge total serum IgE after slender cellular lysate;Using mRNA as template, spy as claimed in claim 1 or 2 Opposite molecule label is that primer reverse transcription synthesizes the first chain cDNA, and the specific molecular label is made to be added in the 5 ' of the first chain cDNA End, and in process of reverse-transcription, using the template switch activity of reverse transcriptase in the 3 ' ends of the first chain cDNA plus the preceding paragraph connector Sequence, the joint sequence with as universal primer sequence shown in SEQ ID NO.1 it is identical;Using the first chain cDNA as template, with such as Universal primer sequence shown in SEQ ID NO.1 is the full-length cDNA that primer passes through PCR amplification anamorphic zone specific molecular label, And pcr amplification product is purified;
2) full-length cDNA obtained by step 1) and transposase embedding compound are incubated for, complete cDNA fragmentation and adjunction Head, wherein transposase embedding compound includes transposase and annealing connector;
3) PCR amplification is carried out to the fragmentation products that step 2) obtains using upstream primer N7 and downstream primer N5;Wherein, The sequence of upstream primer N7 is as shown in SEQ ID NO.4: CAAGCAGAAGACGGCATACGAGATGTCTCGTGGGCTCGG, under The sequence of primer N5 is swum as shown in SEQ ID NO.5: AATGATACGGCGACCACCGAGATCTACACTCGTCGGCAGCGTC;
4) pcr amplification product obtained by step 3) is purified, obtains the end the 5` text of the cDNA with specific molecular label Library.
Further, in step 2), each method processed of the transposase embedding compound includes: preparation system: prepare system: Transposase (10U) 12-15 μ L, annealing 5 μ L of connector, buffer 12-15 μ L is embedded, 33 μ L of total volume is gently blown and beaten with pipettor It mixes, the reaction system prepared is placed in PCR instrument and is reacted 1.5 hours for 30 DEG C, -20 DEG C of preservations.
Transposase in the transposase embedding compound is Tn5 family transposase, wild type Tn5 transposase, saltant type Tn5 transposase is suitable for the present invention;It is described annealing connector nucleotide sequence as shown in SEQ ID NO.6, specifically: CTCTTATACACATCTGACGCTGCCGACGA。
Again, in step 2), the cDNA fragmentation and plus jointing method include: preparation reaction mixture: the swivel base Enzyme embeds compound 3-7 μ l, swivel base enzyme reaction buffer solution 4-8 μ l;By the end 5` plus the specific molecular label cDNA with Reaction mixture mixing, is blown and beaten with pipettor and is mixed;55 DEG C of reaction 10-15min in PCR instrument.
Specific molecular label of the present invention shares 4nKind, by 30 T bases of poly thereon (T) sequence with Poly (A) tail Annealing complementary on mRNA carries out reverse transcription under the action of reverse transcriptase and obtains the first chain cDNA, specificity point Subtab is added in the 5 ' ends of the first chain cDNA, adds one at the 3 ' ends of the first chain cDNA using the template switch activity of reverse transcriptase Section joint sequence identical with universal primer sequence;It is obtained by such as the amplifiable synthesis of universal primer shown in SEQ ID NO.1 Full-length cDNA with specific molecular label, the full-length cDNA is without 3` and 5` Preference.
The banking process of the present invention interrupted using transposase, in cDNA fragmentation process, fragmentation fracture Both ends are coupled with the annealing connector of transposase, i.e., in addition to the end 3` and 5` of cDNA, there is identical move back at the both ends of the DNA of fragmentation Fiery joint sequence P5 (as shown in SEQ ID NO.6);And transposase connector sequence is had on the 5` end-specificity molecular label of cDNA P7 is arranged, therefore using the N7 primer with transposase joint sequence (as shown in SEQ ID NO.2) and with annealing joint sequence The N5 primer of (as shown in SEQID NO.6) can react the end 5` of enrichment cDNA by PCR.Subsequent analysis of biological information It can be by marking the random sequence in the specific molecular label on the end 5` of each cDNA each in library to distinguish The absolute quantitation of cDNA is realized in the source of a cDNA.
In full-length cDNA preparation process, specific molecular label of the present invention is added in the 5 ' ends of the first chain cDNA, from And stamped a random molecular label to each mRNA, make each gene be it is unique, subsequent Even if having different degrees of Preference in the enrichment process of the end cDNA 5`, but for the cDNA of identical molecular label, it can be denoted as and Derived from the same copy, therefore can distinguishing different by the different of molecular label when biological data is analyzed MRNA, to be carried out to the copy number of mRNA accurately quantitative.
Beneficial effects of the present invention:
(1) it is built in library compared with common sequence with existing cDNA, the molecular label that the present invention designs has 4 different sequences Part forms, this 4 parts play different effect: universal primer sequence respectively: due to reverse transcriptase in process of reverse-transcription Template switch activity adds the preceding paragraph sequence identical with universal primer at the end 3` of cDNA, synthesizes by the way that universal primer is amplifiable To the full-length cDNA with specific molecular label;Transposase joint sequence P7: on the 5` end-specificity molecular label of full-length cDNA With transposase joint sequence P7, and in cDNA fragmentation process, the both ends of the DNA of fragmentation have identical annealing to connect Header sequence P5 is connect using the upstream primer N7 with transposase joint sequence P7 (as shown in SEQ ID NO.2) and with annealing The downstream primer N5 of header sequence P5 (as shown in SEQ ID NO.6) can react the end 5` for being only enriched with cDNA by PCR;At random Sequence: each mRNA molecule is marked;Poly (T) sequence: the end 3` poly (A) sequence complementary pairing with mRNA, in reverse transcription Reverse transcription synthesizes the first chain cDNA under the action of enzyme.
(2) compared with existing transposase interrupts banking process, cDNA of the invention builds the embedding of transposase used in library Joint sequence in compound only has a kind of annealing joint sequence P5, by the upstream primer N7 for having transposase joint sequence P7 It is annealing joint sequence P5 that both ends, which can be abandoned, all during PCR with the downstream primer N5 with annealing joint sequence P5 DNA fragmentation and the end 5` for being only enriched with cDNA.Subsequent information analysis only needs the sequence at the end 5` of cDNA just to can know that its representative MRNA, without obtaining the cDNA sequence information of overall length.
(3) molecular label provided by the present invention is added in the end 5` of each cDNA, each gene is made to have an only nothing Two molecular label, subsequent information analysis can quantify each gene in sample according to the sequence of label, and accuracy is significantly It improves.
(4) when the specific molecular label designed by the present invention is applied to construction cDNA library, required starting total amount RNA is low (1-1000 cell, 10pg-10ng), individual cells can be used as starting template and carry out efficient amplification, solve rare sample Measure insufficient problem;Greatly reduce the processing of RNA sample simultaneously, so as to avoid the loss of sample, improve operation at Power.
Specific embodiment
Technical solution of the present invention is described in further detail below in conjunction with specific embodiment.
The specific molecular label of the design of embodiment 1 cDNA
The specific molecular label of cDNA includes:
A, universal primer sequence is used for subsequent PCR amplification full-length cDNA as shown in SEQ ID NO.1, and universal primer is specific Sequence is as follows: AAGCAGTGGTATCAACGCAGAGTAC;
B, transposase joint sequence P7, as shown in SEQ ID NO.2, particular sequence is as follows: GTCTCGTGGGCTCGG AGATGTGTATAAGAGACAG;
C, random sequence (N)n, wherein N is random sequence, total n;
D, poly (T) sequence, totally 30 T base, that is, T30VN;
CDNA molecular label is synthesized by method for synthesizing gene, nucleotide sequence is as shown in SEQ ID NO.3: AAGCAGTGGTATCAACGCAGAGTAC GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAG(N)nT30VN, wherein N For random sequence, total n, N is selected from A, T, C, G;Preferably, n 5-10.
Embodiment 2 prepares the full-length cDNA with the specific molecular label
293 cells for selecting people are experimental material, and the Discover-sc WTA Kit of (Vazyme) is only praised using Nanjing promise V2 (N711) kit carries out transcript profile amplification.Used reagent and material is provided by the kit, for example, unicellular split Solve liquid, RNase Inhibitor, RT Buffer, DTT, TSOligo, reverse transcriptase, high fidelity enzyme etc..
(1) preparation of samples
1) 10 × Sample Buffer is prepared in the following order, is mixed gently with pipettor, and of short duration is collected by centrifugation.
Table 1
Component Volume
Unicellular lysate 19μl
RNase Inhibitor 1μl
Total volume 20μl
2) in the PCR pipe for taking 10 × Sample Buffer to 0.2ml of 1 μ l, the nuclease free pure water of 4 μ l is added (Nuclease-free H2O)。
3) single celled separation
293 cell suspending liquids for taking fresh cultured, are collected by centrifugation at normal temperature, abandon culture solution and PBS is added to be resuspended, aobvious being inverted Single celled selection separation is carried out under micro mirror, and by the isolated unicellular step 2) that is added to containing 10 × Sample In the PCR pipe of the 0.2ml of Buffer, tube wall mixing is flicked, 5min is incubated at room temperature.
(2) first chain cDNA synthesis
1) sample after cracking is placed on ice, prepares reaction mixture according to table 2, then 4 μ l reaction mixtures are added In the unicellular sample cracked to 6 μ l, mixed gently with pipettor, of short duration be collected by centrifugation is placed on ice.
Table 2
Component Volume
The special molecular label as shown in SEQ ID NO.3 2μl
dNTP 2μl
Total volume 4μl
2) 72 DEG C of reaction 3min in PCR instrument, after be immediately placed on 2min on ice.
3) by PCR instrument be preheated to 42 DEG C it is spare.
4) reaction mixture is prepared according to table 3, is mixed gently with pipettor, of short duration be collected by centrifugation is placed on ice.
Table 3
Component Volume
Nuclease-free H2O 2.5μl
Step 2) reaction product 10μl
RT Buffer 4μl
DTT 1μl
RNase Inhibitor 0.5μl
TS Oligo 1μl
Reverse transcriptase 1μl
Total volume 20μl
5) PCR reaction as shown in table 4 is carried out, after reaction place the product on ice, product is the first chain cDNA synthesis Product.
Table 4
Heat lid 105℃
42℃ 90min
70℃ 15min
4℃ It maintains
This step reverse transcription has synthesized the first chain cDNA, and identical as universal primer sequence at the 3 ' ends of cDNA plus the preceding paragraph Joint sequence.
(3) with the full-length cDNA amplification of molecular label
It is primer by PCR amplification synthesis full-length cDNA by the universal primer sequence as shown in SEQ ID NO.1, specifically Steps are as follows:
1) PCR reaction solution as shown in table 5 is configured, is mixed gently with pipettor, of short duration be collected by centrifugation is placed on ice.
Table 5
2) program as shown in table 6 is run in PCR instrument:
Table 6
(4) PCR product purifies
PCR product is adsorbed using the VAHTS DNA Clean Beads (N411) that (Vazyme) is only praised in Nanjing promise, 80% Ethyl alcohol cleans magnetic bead, Elution Buffer elution, and obtained product is the full-length cDNA with specific molecular label.
Embodiment 3 uses the DNA banking process of transposase
(Vazyme) TruePrep DNA Library Prep produced using Nanjing Vazyme Biotechnology Co., Ltd. Kit V2 for Illumina (TD503) kit carries out, and used reagent and material are provided by the kit, for example, Swivel base enzyme buffer liquid, PCR buffer, high fidelity enzyme etc..
(Vazyme) Tn5 that transposase and embedding buffer are produced by Nanjing Vazyme Biotechnology Co., Ltd. Transposome (S111) kit provides.
(1) connector embeds
Reaction system as shown in table 7 is configured, mixing is gently blown and beaten with pipettor, the reaction system prepared is placed in PCR It is reacted 1.5 hours for 30 DEG C on instrument, obtains transposase embedding compound, -20 DEG C of preservations.
Table 7
(2) the full-length cDNA fragmentation with molecular label
1) each reactive component as shown in table 8 is successively added in sterilizing PCR pipe, and mixing is gently blown and beaten using pipettor.
Table 8
Component Volume
1ng cDNA 1μl
Swivel base enzyme buffer liquid 4μl
Transposase embeds compound 5μl
ddH2O 40μl
Total 50μl
2) PCR reaction as shown in table 9 is carried out, 5 × TS of 5 μ l is added into reaction product immediately, gently using pipettor Piping and druming mixes, and is placed at room temperature for 5min.
Table 9
Heat lid 105℃
55℃ 10min
10℃ Hold
(3) PCR is enriched with the 5 ' ends of cDNA
1) PCR reaction solution as shown in table 10 is configured, is mixed gently with pipettor, of short duration be collected by centrifugation is placed on ice.
Table 10
Wherein, the sequence of upstream primer N7 is as shown in SEQ ID NO.4: CAAGCAGAAGACGGCATACGAGATxxxxx XxxGTCTCGTGGGCTCGG, wherein xxxxxxxx is index sequence;The sequence of downstream primer N5 is as shown in SEQ ID NO.5: AATGATACGGCGACCACCGAGATCTACACxxxxxxxxTCGTCGGCAGCGTC, xxxxxxxx are index sequence.
2) program as shown in table 11 is run in PCR instrument:
Table 11
(3) PCR product purifies
The VAHTS DNA CleanBeads of (Vazyme) Biotechnology Co., Ltd production is only praised using Nanjing promise (N411) PCR product is adsorbed, 80% ethyl alcohol cleans magnetic bead, Elution Buffer elution, and finally obtained product is richness Collect the library at the 5 ' ends of cDNA.
Finally it should be noted that the above examples are only used to illustrate the technical scheme of the present invention and are not limiting, although ginseng It is described the invention in detail according to preferred embodiment, those skilled in the art should understand that, it can be to invention Technical solution is modified or replaced equivalently, and without departing from the spirit and scope of the technical solution of the present invention, should all be covered In scope of the presently claimed invention.
Sequence table
<110>Nanjing Vazyme Biotechnology Co., Ltd.
<120>the specific molecular label of cDNA a kind of and its application
<160> 6
<210>SEQ ID NO. 1
<211>25
<212>DNA
<213>artificial synthesized
AAGCAGTGGTATCAACGCAGAGTAC
<210>SEQ ID NO. 2
<211>34
<212>DNA
<213>artificial synthesized
GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAG
<210>SEQ ID NO. 3
<211>61
<212>DNA
<213>artificial synthesized
AAGCAGTGGTATACGCAGAGTACGTTCGTGGGCTCGGTTCATAAGAGACAGNNNNNNNT30VN
<210>SEQ ID NO. 4
<211>39
<212>DNA
<213>artificial synthesized
CAAGCAGAAGACGGCATACGAGATGTCTCGTGGGCTCGG
<210>SEQ ID NO. 5
<211>43
<212>DNA
<213>artificial synthesized
AATGATACGGCGACCACCGAGATCTACACTCGTCGGCAGCGTC
<210>SEQ ID NO. 6
<211>29
<212>DNA
<213>artificial synthesized
CTCTTATACACATCTGACGCTGCCGACGA

Claims (6)

1. the specific molecular label of cDNA a kind of, which is characterized in that the nucleotide sequence such as SEQ of the specific molecular label Shown in ID NO.3, particular sequence is as follows: AAGCAGTGGTATCAACGCAGAGTACGTCTCGTGGGCTCGGAGATGTGTATA AGAGACAG(N)nT30VN, wherein N is random sequence, total n, n 5-10.
2. the specific molecular label of cDNA as described in claim 1 builds the application in library in cDNA.
3. the specific molecular label of cDNA as described in claim 1 builds the application in library in the cDNA interrupted using transposase.
4. a kind of cDNA banking process interrupted using transposase, which comprises the steps of:
1) separation is unicellular, will discharge total serum IgE after slender cellular lysate;Using mRNA as specific molecular described in template, claim 1 Label is that primer reverse transcription synthesizes the first chain cDNA, and the specific molecular label is added in the 5 ' ends of the first chain cDNA, and inverse In transcription, using the template switch activity of reverse transcriptase in the 3 ' ends of the first chain cDNA plus the preceding paragraph joint sequence, this is connect Header sequence with as universal primer sequence shown in SEQ ID NO.1 it is identical;Using the first chain cDNA as template, with such as SEQ IDNO.1 Shown in universal primer sequence be full-length cDNA of the primer by specific molecular label described in PCR amplification anamorphic zone, and carry out Purifying;
2) full-length cDNA obtained by step 1) and transposase embedding compound are incubated for, complete cDNA fragmentation and adjunction head; Wherein, the transposase embedding compound includes transposase and annealing connector;
3) PCR amplification is carried out to the resulting fragmentation products of step 2) using upstream primer N7 and downstream primer N5, is enriched with cDNA 5 ' end;Wherein, the sequence of upstream primer N7 is as shown in SEQ ID NO.4, the sequence of downstream primer N5 such as SEQ ID NO.5 institute Show;
4) pcr amplification product obtained by step 3) is purified, obtains 5 ' the end texts of the cDNA with the specific molecular label Library.
5. the cDNA banking process according to claim 4 interrupted using transposase, which is characterized in that in step 2), institute The nucleotide sequence of the annealing connector in transposase embedding compound is stated as shown in SEQ ID NO.6;The transposase is Tn5 Family's transposase.
6. the cDNA banking process according to claim 4 or 5 interrupted using transposase, which is characterized in that in step 2), The cDNA fragmentation and plus jointing method include: preparation reaction mixture: the transposase embedding of claim 4 or 5 is multiple Close object 3-7 μ l, swivel base enzyme reaction buffer solution 4-8 μ l;Full-length cDNA is mixed with reaction mixture, is blown and beaten and is mixed with pipettor; The 50-58 DEG C of reaction 10-15min in PCR instrument.
CN201611196752.5A 2016-12-21 2016-12-21 The specific molecular label of cDNA a kind of and its application Active CN106754904B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201611196752.5A CN106754904B (en) 2016-12-21 2016-12-21 The specific molecular label of cDNA a kind of and its application

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201611196752.5A CN106754904B (en) 2016-12-21 2016-12-21 The specific molecular label of cDNA a kind of and its application

Publications (2)

Publication Number Publication Date
CN106754904A CN106754904A (en) 2017-05-31
CN106754904B true CN106754904B (en) 2019-03-15

Family

ID=58899231

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201611196752.5A Active CN106754904B (en) 2016-12-21 2016-12-21 The specific molecular label of cDNA a kind of and its application

Country Status (1)

Country Link
CN (1) CN106754904B (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107502607A (en) * 2017-06-20 2017-12-22 浙江大学 A kind of a large amount of tissues, cell sample mRNA molecular barcode mark, library construction, the method for sequencing
WO2019129133A1 (en) * 2017-12-28 2019-07-04 深圳华大智造科技有限公司 Method for obtaining single-cell mrna sequence
CN109971849A (en) * 2017-12-28 2019-07-05 安诺优达基因科技(北京)有限公司 The unicellular multisample mixing banking process of liver cancer related gene
CN108410970A (en) * 2018-03-12 2018-08-17 博奥生物集团有限公司 A kind of detection method and kit of unicellular genome copies number variation
CN108410856A (en) * 2018-03-29 2018-08-17 武汉光谷创赢生物技术开发有限公司 A kind of structure of full-length cDNA synthetic method and its sequencing library
CN108611346A (en) * 2018-05-06 2018-10-02 湖南大地同年生物科技有限公司 A kind of construction method in unicellular gene expression amount detection library
CN108949909A (en) * 2018-07-17 2018-12-07 厦门生命互联科技有限公司 A kind of blood platelet nucleic acid library construction method and kit for genetic test
CN109658981B (en) * 2018-12-10 2022-10-04 海南大学 Data classification method for single cell sequencing
CN109988819A (en) * 2019-04-19 2019-07-09 南京诺唯赞生物科技有限公司 A kind of specific linkers molecular label and its application in prediction variable sheer
CN110257479A (en) * 2019-06-25 2019-09-20 北京全式金生物技术有限公司 A kind of method that rapid build RNA 3 ' holds gene expression library
CN110241178B (en) * 2019-06-25 2023-03-31 北京博奥晶方生物科技有限公司 Single-cell transcriptome sequencing high-throughput rapid library preparation method and detection kit
CN113444770B (en) * 2020-03-27 2023-05-30 中国人民解放军陆军军医大学 Construction method and application of single-cell transcriptome sequencing library
CN115386622B (en) * 2022-10-26 2023-10-27 北京寻因生物科技有限公司 Library construction method of transcriptome library and application thereof
CN116904445B (en) * 2023-09-12 2023-12-29 南京诺唯赞生物科技股份有限公司 mRNA enrichment method

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101921840A (en) * 2010-06-30 2010-12-22 深圳华大基因科技有限公司 DNA molecular label technology and DNA incomplete interrupt policy-based PCR sequencing method
US20110281736A1 (en) * 2009-11-30 2011-11-17 Complete Genomics, Inc. Nucleic Acid Sequencing and Process
CN104711250A (en) * 2015-01-26 2015-06-17 北京百迈客生物科技有限公司 Building method of long fragment nucleic acid library

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110281736A1 (en) * 2009-11-30 2011-11-17 Complete Genomics, Inc. Nucleic Acid Sequencing and Process
CN101921840A (en) * 2010-06-30 2010-12-22 深圳华大基因科技有限公司 DNA molecular label technology and DNA incomplete interrupt policy-based PCR sequencing method
CN104711250A (en) * 2015-01-26 2015-06-17 北京百迈客生物科技有限公司 Building method of long fragment nucleic acid library

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DNA分子标记研究进展;黄映萍;《中山大学研究生学刊(自然科学,医学版)》;20101231;第31卷(第2期);第27-36页

Also Published As

Publication number Publication date
CN106754904A (en) 2017-05-31

Similar Documents

Publication Publication Date Title
CN106754904B (en) The specific molecular label of cDNA a kind of and its application
Li et al. Understanding the functions of long non-coding RNAs through their higher-order structures
Van Dijk et al. Library preparation methods for next-generation sequencing: tone down the bias
Mata Genome-wide mapping of polyadenylation sites in fission yeast reveals widespread alternative polyadenylation
CN113444770B (en) Construction method and application of single-cell transcriptome sequencing library
JPH07500735A (en) Messenger RNA identification, isolation and cloning
CN111315884B (en) Normalization of sequencing libraries
WO2021184146A1 (en) Method for constructing sequencing library of an rna sample to be sequenced
CN110396534A (en) The construction method of gene library, determined nucleic acid sample gene mutation detection method and kit
US11761037B1 (en) Probe and method of enriching target region applicable to high-throughput sequencing using the same
CN110004210A (en) A method of for constructing bacterial 16 S rDNA overall length high-throughput sequencing library
CN101082060B (en) New micro ribonucleic acid quantitative PCR (polymerase chain reaction) detection method
CN108193283A (en) A kind of unicellular transcript profile library method for building up and its application
CN110157785A (en) A kind of unicellular RNA sequencing library construction method
CN110241178A (en) A kind of unicellular transcript profile sequencing high-throughput quickly library preparation method and detection kit
CN108588176A (en) A method of R-loop high-throughput sequencing libraries are built based on single stranded DNA
CN108192893B (en) Method for developing blumea balsamifera SSR primer based on transcriptome sequencing
Maguire et al. Rolling circle reverse transcription enables high fidelity nanopore sequencing of small RNA
CN108251503A (en) A kind of method of rapid build chain specific RNA high-throughput sequencing library
CN111647644B (en) Library construction method based on novel coronavirus specific reverse transcription primer and application thereof
Lin et al. Transcriptome analysis reveals the molecular mechanisms underlying adenosine biosynthesis in anamorph strain of caterpillar fungus
CN109971843A (en) A kind of sequencing approach of unicellular transcript profile
CN115058490B (en) Primer combination for constructing microorganism targeted sequencing library and application thereof
WO2020159435A1 (en) Method of sequencing nucleic acid with unnatural base pairs
WO2020259303A1 (en) Method for rapid construction of rna 3&#39;-end gene expression library

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
CP01 Change in the name or title of a patent holder
CP01 Change in the name or title of a patent holder

Address after: Qixia District of Nanjing City, Jiangsu province 210038 Branch Road, Hongfeng Technology Park building C1-2

Patentee after: Nanjing novozan Biotechnology Co., Ltd

Address before: Qixia District of Nanjing City, Jiangsu province 210038 Branch Road, Hongfeng Technology Park building C1-2

Patentee before: VAZYME BIOTECH (NANJING) Co.,Ltd.